• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可视化无形之物:无症状传播对新冠疫情动态的影响。

Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.

作者信息

Peirlinck Mathias, Linka Kevin, Costabal Francisco Sahli, Bhattacharya Jay, Bendavid Eran, Ioannidis John P A, Kuhl Ellen

机构信息

Department of Mechanical Engineering, Stanford University School of Engineering, Stanford, California, United States.

Department of Mechanical and Metallurgical Engineering and Institute for Biological and Medical Engineering, Schools of Engineering, Biology and Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.

出版信息

medRxiv. 2020 Aug 29:2020.05.23.20111419. doi: 10.1101/2020.05.23.20111419.

DOI:10.1101/2020.05.23.20111419
PMID:32869035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7457606/
Abstract

Understanding the outbreak dynamics of the COVID-19 pandemic has important implications for successful containment and mitigation strategies. Recent studies suggest that the population prevalence of SARS-CoV-2 antibodies, a proxy for the number of asymptomatic cases, could be an order of magnitude larger than expected from the number of reported symptomatic cases. Knowing the precise prevalence and contagiousness of asymptomatic transmission is critical to estimate the overall dimension and pandemic potential of COVID-19. However, at this stage, the effect of the asymptomatic population, its size, and its outbreak dynamics remain largely unknown. Here we use reported symptomatic case data in conjunction with antibody seroprevalence studies, a mathematical epidemiology model, and a Bayesian framework to infer the epidemiological characteristics of COVID-19. Our model computes, in real time, the time-varying contact rate of the outbreak, and projects the temporal evolution and credible intervals of the effective reproduction number and the symptomatic, asymptomatic, and recovered populations. Our study quantifies the sensitivity of the outbreak dynamics of COVID-19 to three parameters: the effective reproduction number, the ratio between the symptomatic and asymptomatic populations, and the infectious periods of both groups For nine distinct locations, our model estimates the fraction of the population that has been infected and recovered by Jun 15, 2020 to 24.15% (95% CI: 20.48%-28.14%) for Heinsberg (NRW, Germany), 2.40% (95% CI: 2.09%-2.76%) for Ada County (ID, USA), 46.19% (95% CI: 45.81%-46.60%) for New York City (NY, USA), 11.26% (95% CI: 7.21%-16.03%) for Santa Clara County (CA, USA), 3.09% (95% CI: 2.27%-4.03%) for Denmark, 12.35% (95% CI: 10.03%-15.18%) for Geneva Canton (Switzerland), 5.24% (95% CI: 4.84%-5.70%) for the Netherlands, 1.53% (95% CI: 0.76%-2.62%) for Rio Grande do Sul (Brazil), and 5.32% (95% CI: 4.77%-5.93%) for Belgium. Our method traces the initial outbreak date in Santa Clara County back to January 20, 2020 (95% CI: December 29, 2019 - February 13, 2020). Our results could significantly change our understanding and management of the COVID-19 pandemic: A large asymptomatic population will make isolation, containment, and tracing of individual cases challenging. Instead, managing community transmission through increasing population awareness, promoting physical distancing, and encouraging behavioral changes could become more relevant.

摘要

了解新冠疫情的暴发动态对于成功的防控和缓解策略具有重要意义。近期研究表明,SARS-CoV-2抗体在人群中的流行率(可作为无症状病例数量的一个指标)可能比报告的有症状病例数量所预期的要高出一个数量级。了解无症状传播的确切流行率和传染性对于评估新冠疫情的总体规模和大流行潜力至关重要。然而,在现阶段,无症状人群的影响、其规模及其暴发动态在很大程度上仍不为人知。在此,我们结合报告的有症状病例数据、抗体血清流行率研究、数学流行病学模型和贝叶斯框架来推断新冠疫情的流行病学特征。我们的模型实时计算疫情随时间变化的接触率,并预测有效再生数以及有症状、无症状和康复人群的时间演变和可信区间。我们的研究量化了新冠疫情暴发动态对三个参数的敏感性:有效再生数、有症状和无症状人群之间的比例以及两组人群的传染期。对于九个不同地点,我们的模型估计,截至2020年6月15日,德国北莱茵-威斯特法伦州海因斯贝格已感染并康复的人口比例为24.15%(95%置信区间:20.48%-28.14%),美国爱达荷州阿达县为2.40%(95%置信区间:2.09%-2.76%),美国纽约市为46.19%(95%置信区间:45.81%-46.60%),美国加利福尼亚州圣克拉拉县为11.26%(95%置信区间:7.21%-16.03%),丹麦为3.09%(95%置信区间:2.27%-4.03%),瑞士日内瓦州为12.35%(95%置信区间:10.03%-15.18%),荷兰为5.24%(95%置信区间:4.84%-5.70%),巴西南里奥格兰德州为1.53%(95%置信区间:0.76%-2.62%),比利时为5.32%(95%置信区间:4.77%-5.93%)。我们的方法将圣克拉拉县的初始疫情日期追溯到2020年1月20日(95%置信区间:2019年12月29日 - 2020年2月13日)。我们的结果可能会显著改变我们对新冠疫情的理解和管理:大量无症状人群将使对个别病例的隔离、防控和追踪变得具有挑战性。相反,通过提高公众意识、促进物理距离和鼓励行为改变来管理社区传播可能会变得更加重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/c1f68669296d/nihpp-2020.05.23.20111419-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/1e371adc5d4b/nihpp-2020.05.23.20111419-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/82a4a9ea3af1/nihpp-2020.05.23.20111419-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/cd579da6345d/nihpp-2020.05.23.20111419-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/50fa1b63dd68/nihpp-2020.05.23.20111419-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/15aeb895b193/nihpp-2020.05.23.20111419-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/7ceae3611db4/nihpp-2020.05.23.20111419-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/8edcaa5863e5/nihpp-2020.05.23.20111419-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/4bc30475a7b3/nihpp-2020.05.23.20111419-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/c1f68669296d/nihpp-2020.05.23.20111419-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/1e371adc5d4b/nihpp-2020.05.23.20111419-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/82a4a9ea3af1/nihpp-2020.05.23.20111419-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/cd579da6345d/nihpp-2020.05.23.20111419-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/50fa1b63dd68/nihpp-2020.05.23.20111419-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/15aeb895b193/nihpp-2020.05.23.20111419-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/7ceae3611db4/nihpp-2020.05.23.20111419-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/8edcaa5863e5/nihpp-2020.05.23.20111419-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/4bc30475a7b3/nihpp-2020.05.23.20111419-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/7457606/c1f68669296d/nihpp-2020.05.23.20111419-f0009.jpg

相似文献

1
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.可视化无形之物:无症状传播对新冠疫情动态的影响。
medRxiv. 2020 Aug 29:2020.05.23.20111419. doi: 10.1101/2020.05.23.20111419.
2
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.可视化无形之物:无症状传播对新冠疫情动态的影响。
Comput Methods Appl Mech Eng. 2020 Dec 1;372:113410. doi: 10.1016/j.cma.2020.113410. Epub 2020 Sep 8.
3
Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach.追踪意大利伦巴第地区的零号病人并预测 COVID-19 疫情:一种房室模型和数值优化方法。
PLoS One. 2020 Oct 30;15(10):e0240649. doi: 10.1371/journal.pone.0240649. eCollection 2020.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future.2020 年 2 月至 10 月期间丹麦的 SARS-CoV-2 感染动态:过去疫情的性质及其未来可能的发展。
PLoS One. 2021 Apr 9;16(4):e0249733. doi: 10.1371/journal.pone.0249733. eCollection 2021.
6
Estimating asymptomatic, undetected and total cases for the COVID-19 outbreak in Wuhan: a mathematical modeling study.估算武汉 COVID-19 疫情中的无症状、未检出和总病例数:一项数学建模研究。
BMC Infect Dis. 2021 May 25;21(1):476. doi: 10.1186/s12879-021-06078-8.
7
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
8
Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.作者回复:在德国首次大流行期间,工人的职业与 SARS-CoV-2 感染风险:潜在的偏见。
Scand J Work Environ Health. 2022 Sep 1;48(7):588-590. doi: 10.5271/sjweh.4061. Epub 2022 Sep 25.
9
Role of Asymptomatic COVID-19 Cases in Viral Transmission: Findings From a Hierarchical Community Contact Network Model.无症状新冠病例在病毒传播中的作用:来自分层社区接触网络模型的发现
IEEE Trans Autom Sci Eng. 2021 Sep 3;19(2):576-585. doi: 10.1109/TASE.2021.3106782. eCollection 2022 Apr.
10
The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak.无症状传播的时间尺度会影响对新冠疫情爆发中流行潜力的估计。
medRxiv. 2020 Apr 14:2020.03.09.20033514. doi: 10.1101/2020.03.09.20033514.

本文引用的文献

1
Lessons drawn from China and South Korea for managing COVID-19 epidemic: Insights from a comparative modeling study.从中国和韩国管理 COVID-19 疫情中吸取的教训:一项比较建模研究的启示。
ISA Trans. 2022 May;124:164-175. doi: 10.1016/j.isatra.2021.12.004. Epub 2021 Dec 28.
2
Infection fatality rate of COVID-19 inferred from seroprevalence data.基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
3
COVID-19 antibody seroprevalence in Santa Clara County, California.
加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
4
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.SARS-CoV-2 血清流行率趋势在 COVID-19 爆发期间在米兰的健康献血者中。
Blood Transfus. 2021 May;19(3):181-189. doi: 10.2450/2021.0324-20. Epub 2021 Feb 3.
5
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.通过实时献血者抗体筛查估计 SARS-CoV-2 感染病死率。
Clin Infect Dis. 2021 Jan 27;72(2):249-253. doi: 10.1093/cid/ciaa849.
6
Global and local mobility as a barometer for COVID-19 dynamics.全球和本地流动性作为 COVID-19 动态的晴雨表。
Biomech Model Mechanobiol. 2021 Apr;20(2):651-669. doi: 10.1007/s10237-020-01408-2. Epub 2021 Jan 15.
7
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.2020 年 4 月伊朗吉兰省 SARS-CoV-2 的血清流行率。
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
8
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.德国超级传播事件中 SARS-CoV2 的感染病死率。
Nat Commun. 2020 Nov 17;11(1):5829. doi: 10.1038/s41467-020-19509-y.
9
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.SARS-CoV-2 血清阳性率及中和活性在供者和患者血液中的变化。
Nat Commun. 2020 Sep 17;11(1):4698. doi: 10.1038/s41467-020-18468-8.
10
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia.克罗地亚斯普利特-达尔马提亚省和希贝尼克-克宁县工业工人中 SARS-CoV-2 抗体血清阳性率。
J Occup Environ Med. 2021 Jan 1;63(1):32-37. doi: 10.1097/JOM.0000000000002020.